Skip to content
10-K

Annual Report

Puramed Bioscience Inc.

0001354488-13-005721

← back to feed
Filed
Oct 15, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2013 · Oct 2, 2013 59.99M sh
Capex FY 2013 · Jun 30, 2012 $927
Operating Cash Flow FY 2013 · Jun 30, 2012 −$704.71K
Short Term Debt FY 2013 · Jun 30, 2012 $43.94K
Current Liabilities FY 2013 · Jun 30, 2012 $1.47M
Current Assets FY 2013 · Jun 30, 2012 $209.42K
Total Assets FY 2013 · Jun 30, 2012 $400.47K
Sga Expense FY 2013 · Jun 30, 2012 $180.75K
Rd Expense FY 2013 · Jun 30, 2012 $17.98K
Net Income FY 2013 · Jun 30, 2012 −$1.72M
Operating Income FY 2013 · Jun 30, 2012 −$1.35M
Gross Profit FY 2013 · Jun 30, 2012 $509.32K
Cost Of Revenue FY 2013 · Jun 30, 2012 $183.75K
Revenue FY 2013 · Jun 30, 2012 $693.06K
Stockholders Equity FY 2013 · Jun 30, 2011 −$764.92K